MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MRVL

Go back to MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2
Miracle Applications Corp (NASDAQ: MIRA) Delayed: 0.94 -0.02 (2.08%)
Previous Close $0.96    52 Week High $0.04 
Open $0.96    52 Week Low $0.00 
Day High $0.98    P/E N/A 
Day Low $0.94    EPS $0.00 
Volume 123,063